CAPR SCHEDULE 13G: SEC filing
Millennium Management LLC and affiliated entities
Filed with the SEC on · accession 0001104659-26-107591
CAPR filed a SCHEDULE 13G (schedule 13g) with the SEC on Sep 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +5.3% by the first close after the filing.
Summary of the filing
Millennium Management LLC and affiliated entities filed a Schedule 13G indicating beneficial ownership of Capricor Therapeutics common stock, accompanied by a joint filing agreement.
Key details
How CAPR stock reacted
Close before
$8.37
Sep 11, 2026
First close after
+5.26%
$8.81
5 trading days
+8.24%
$9.06
Since filing
+2.75%
$8.60
✦ Ask GOAX AI about this filing — what it means for CAPR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CAPR?
Click hereFrequently asked questions
What did CAPR file with the SEC on Sep 14, 2026?
CAPR filed a SCHEDULE 13G (SEC filing). Millennium Management LLC and affiliated entities filed a Schedule 13G indicating beneficial ownership of Capricor Therapeutics common stock, accompanied by a joint filing agreement.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did CAPR stock react to this filing?
CAPR closed at $8.37 before the filing and $8.81 on Sep 14, 2026 (+5.26%). Five trading days later: $9.06 (+8.24%).
Other CAPR SEC filings
- 8-K · SEC filingAug 24, 2026
- 10-Q · SEC filingAug 14, 2026
- 8-K · SEC filingAug 13, 2026
- 8-K · Fda rejectionJul 30, 2026
- 8-K · Fda approvalJul 29, 2026
- 8-K · Material agreementJul 14, 2026
- 8-K · Fda approvalJun 26, 2026
- 8-K · Board changeJun 8, 2026
- 144 · Insider sale plannedMay 19, 2026
- 10-Q · SEC filingMay 13, 2026
Get alerts when CAPR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days